The Cambridge Center for Medical & Veterinary Sciences Inc. (CMVS) is focusing its efforts (PHASE ONE of the project) to raise USD 1.6 million for the purpose of establishing kidney transplant program for clinically diagnosed uremic dogs in Greater Toronto Area (GTA) in Ontario, Canada. This will be the first and only such program established in Canada and the U.S.A. In this PHASE ONE, the Company is planning to establish a new 2,500 sq. ft. – 5,000 sq. ft. FACILITY in GTA, where the clinical kidney transplant program for uremic dogs, a lifesaving procedure provided for terminally ill patients, and the staff involved in the transplant program can be incorporated. The FACILITY will provide an environment for generating a revenue (organ transplantation, daily routine in- & out- patient clinical work, auxiliary services, etc.) in the amount of USD 750.000 (very conservative approach) in its first operational year– and the return on investment. Currently, there are no clinical kidney transplant programs for dogs with diagnosed end-stage-kidney disease established in Canada and in the USA.
Approximately 2.25 million of our pets, dogs and cats (1.5% of total population of 150 million), are diagnosed every year with uremia and / or diabetes, of which 40% - 50% are euthanized due to lack of treatment . This licenced FACILITY will set-up a fundamental platform to create a teaching-learning institution as it has been outline in the Phase 2 of this project. GTA is a very unique and only such place (a strip 150 km long and 50 km wide along Lake of Ontario) on the North American continent due to its geography (Grate Lakes – 18 % of the world's fresh lake water), climate (mild winters and hot summers), population (most populous urban region in Canada, with over 5 million people and expected to add another 2.5 to 4 million by 2020), economy (revenue: C$21 billion / year, and rising), and education (numerous of highly educated individuals holding their PhD degrees).